Crohn’s Disease Research Could Benefit From discovery of Small Molecule Associated With Inflammatory Cell Death

Crohn’s Disease Research Could Benefit From discovery of Small Molecule Associated With Inflammatory Cell Death
shutterstock_150009971A new study, entitled “Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death” published in the journal Proceedings of the National Academy of Sciences by Dr Joanne Hildebrand, part of  Professor John Silke’s research group from Cell Signaling and Cell Death division at The Walter and Eliza Hall Institute of Medical Research in Australia, has identified a small molecule that inhibits necroptosis, a form of cell death, that induces inflammation. The new discovery may pave the way for potential new therapies for inflammatory diseases such as rheumatoid arthritis, Crohn’s disease and psoriasis. Necroptosis is considered to be complementary to the classical caspase-dependent programmed cell death pathway, while apoptosis is a recently discovered cell death pathway linked to immune disorders. It is a vital process in which cells undergo programmed death while warning the immune system that something has gone wrong, such as during viral infection. But when necroptosis is improperly activated, it can induce inflammation and the development of inflammatory diseases. Dr. Joanne Hildebrand, Ms. Maria Tanzer, and collaborators were elucidating the mechanism of killing by t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *